Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
I. Lempesis, D. Magouliotis, V. Tasiopoulou, E. Solenov, R. Jagirdar, A. Ilyaskin, C. Hatzoglou, P. A. Molyvdas, K. Gourgoulianis, S. Zarogiannis (Larissa, Greece; Novosibirsk, Russian Federation). Differential gene expression of two-pore-domain potassium channels in malignant pleural mesothelioma. Eur Respir J 2013; 42: Suppl. 57, 2928

Member's Comments

No comment yet.

Related content which might interest you: Over-expression of chloride intracellular channels (CLICs) 3 and 4 in malignant pleural mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 beta1 and beta2 adrenergic receptors are significantly under-expressed in malignant pleural mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Effect of asbestos on gene expression of tight junctions components in malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Gene expression mapping to diagnose malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002 Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Volume quantification of malignant pleural mesothelioma Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Role of tumor derived versican in experimental malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Differential expression of tenascin C splice variants in endobronchial epithelial-lining fluid in proximity of pulmonary nodules Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Expression of c-met in malignant pleural mesothelioma; an immunohistochemical study Source: Annual Congress 2007 - Inorganic dust "old timers and new kids on the block" Year: 2007 Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Hypertonicity increases apparent water permeability in benign mesothelial cells but differentially regulates it in epithelioid mesothelioma cells depending on the osmotic agent Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004 High fluorescence cells in pleural fluid. Association with pleural malignancy Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Malignant pleural mesothelioma: A retrospective analysis of 32 cases Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016